Hartline Investment Corp Johnson & Johnson Transaction History

Hartline Investment Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$155.22 - $162.74 $3.53 Million - $3.7 Million	22,741 New	22,741 $3.6 Million
Q3 2022 Nov 01, 2022	BUY	$161.33 - $179.52 $343,955 - $382,736	2,132 New	2,132 $348,000
Q2 2019 Aug 08, 2019	SELL	$131.15 - $144.24 $220,594 - $242,611	-1,682 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $1,842 - $2,217	-15 Reduced 0.88%	1,682 $217,000
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $15,637 - $18,517	125 Added 7.95%	1,697 $217,000
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $787 - $861	6 Added 0.38%	1,572 $220,000
Q3 2017 Nov 20, 2017	BUY	$129.47 - $135.38 $202,750 - $212,005	1,566	1,566 $204,000

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Hartline Investment Corp with notifications on news.